id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-P-0086-0030,FDA,FDA-2008-P-0086,Cheeses and Related CheeseProducts; Proposal To Permit the Use of Ultrafiltered Milk; Reopening the Comment Period,Proposed Rule,Reopening of Comment Period,2019-12-30T05:00:00Z,2019,12,2019-12-30T05:00:00Z,,2020-04-15T20:32:35Z,2019-28145,0,0,0900006484256f2a
FDA-2019-N-5711-0001,FDA,FDA-2019-N-5711,Importation of Prescription Drugs,Proposed Rule,Amendment,2019-12-23T05:00:00Z,2019,12,2019-12-23T05:00:00Z,2020-03-10T03:59:59Z,2022-01-18T02:00:13Z,2019-27474,0,0,090000648424842c
FDA-2019-N-3101-0001,FDA,FDA-2019-N-3101,Revised Procedures for the Announcement of Approvals and Denials of Premarket Approval Applications and Humanitarian Device Exemption Applications,Proposed Rule,Amendment,2019-12-17T05:00:00Z,2019,12,2019-12-17T05:00:00Z,2020-03-03T04:59:59Z,2020-03-04T02:02:53Z,2019-27045,0,0,090000648421ceeb
FDA-2017-F-4399-0010,FDA,FDA-2017-F-4399,Zinpro Corp.; Filing of Food Additive Petition (Animal Use),Proposed Rule,Amendment,2019-11-29T05:00:00Z,2019,11,2019-11-29T05:00:00Z,2019-12-31T04:59:59Z,2020-01-01T02:02:15Z,2019-25903,0,0,09000064841c8875
FDA-2019-F-5401-0001,FDA,FDA-2019-F-5401,Alzchem Trostberg GmbH; Filing of Food Additive Petition (Animal Use),Proposed Rule,Amendment,2019-11-29T05:00:00Z,2019,11,2019-11-29T05:00:00Z,,2019-11-29T19:16:58Z,2019-25904,0,0,09000064841c88e2
FDA-2019-N-2854-0663,FDA,FDA-2019-N-2854,Premarket Tobacco Product Applications and Recordkeeping Requirements; Reopening of the Comment Period,Proposed Rule,Reopening of Comment Period,2019-11-26T05:00:00Z,2019,11,2019-11-26T05:00:00Z,2019-12-17T04:59:59Z,2019-12-18T02:01:22Z,2019-25675,0,0,09000064841b74c6
FDA-2019-N-3065-0484,FDA,FDA-2019-N-3065,Tobacco Products; Required Warnings for Cigarette Packages and Advertisements; Additional Materials; Reopening of the Comment Period,Proposed Rule,Reopening of Comment Period,2019-11-12T05:00:00Z,2019,11,2019-11-12T05:00:00Z,2019-11-28T04:59:59Z,2019-11-12T15:05:34Z,2019-24511,0,0,09000064841433d1
FDA-2019-N-3325-0001,FDA,FDA-2019-N-3325,Laboratory Accreditation for Analyses of Foods,Proposed Rule,Advance Notice of Proposed Rulemaking (ANPRM),2019-11-04T05:00:00Z,2019,11,2019-11-04T05:00:00Z,2020-07-07T03:59:59Z,2020-07-08T01:02:34Z,2019-23870,0,0,090000648411a07f
FDA-2016-D-2343-0070,FDA,FDA-2016-D-2343,Hazard Analysis and Risk-Based Preventive Controls for Human Food; Draft Guidance for Industry; Availability,Proposed Rule,GDL Guidance,2019-10-07T04:00:00Z,2019,10,2019-10-07T04:00:00Z,2020-02-05T04:59:59Z,2024-05-31T13:17:40Z,2019-21643,0,0,09000064840489c1
FDA-2019-F-3911-0001,FDA,FDA-2019-F-3911,Evonik Corp.; Filing of Food Additive Petition (Animal Use),Proposed Rule,Notice of Proposed Rulemaking (NPRM),2019-10-01T04:00:00Z,2019,10,2019-10-01T04:00:00Z,,2019-10-01T12:34:28Z,2019-20958,0,0,0900006483ff2174
FDA-2019-N-2854-0001,FDA,FDA-2019-N-2854,Premarket Tobacco Product Applications and Recordkeeping Requirements,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2019-09-25T04:00:00Z,2019,9,2019-09-25T04:00:00Z,2019-12-17T04:59:59Z,2019-12-18T02:00:32Z,2019-20315,0,0,0900006483fc33e2
FDA-2019-N-0463-0001,FDA,FDA-2019-N-0463,Addition of a New Method for the Analysis of Sulfites in Foods,Proposed Rule,Amendment,2019-09-17T04:00:00Z,2019,9,2019-09-17T04:00:00Z,2019-10-18T03:59:59Z,2019-09-26T01:02:20Z,2019-19862,0,0,0900006483f861a0
FDA-2019-N-3631-0001,FDA,FDA-2019-N-3631,Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies; Public Hearing; Request for Comments,Proposed Rule,Notice of Hearing,2019-09-11T04:00:00Z,2019,9,2019-09-11T04:00:00Z,2020-01-22T04:59:59Z,2020-01-23T02:00:47Z,2019-19643,0,0,0900006483f36791
FDA-2018-N-4845-0001,FDA,FDA-2018-N-4845,"Amendments to the List of Bulk Drug Substances That Can Be Used to
Compound Drug Products in Accordance With Section 503A of the Federal Food, Drug, and Cosmetic Act",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2019-09-05T04:00:00Z,2019,9,2019-09-05T04:00:00Z,2019-12-05T04:59:59Z,2019-12-06T02:01:33Z,2019-18951,0,0,0900006483eed96e
FDA-1998-N-1001-0002,FDA,FDA-1998-N-1001,Ophthalmic Drug Products for Over-The-Counter Human Use; Proposed Amendment of Final Monograph,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2019-08-26T04:00:00Z,2019,8,2019-08-26T04:00:00Z,1998-05-24T03:59:59Z,2019-08-26T19:16:37Z,98-4531,0,0,09000064805a28d5
FDA-2019-N-2514-0025,FDA,FDA-2019-N-2514,Standards for Future Opioid Analgesic Approvals and Incentives for New Therapeutics To Treat Pain and Addiction; Public Hearing; Correction,Proposed Rule,Correction,2019-08-22T04:00:00Z,2019,8,2019-08-22T04:00:00Z,,2019-08-22T13:40:07Z,2019-18090,0,0,0900006483e8c3b6
FDA-2019-N-3065-0001,FDA,FDA-2019-N-3065,"Tobacco Products; Required Warnings for Cigarette Packages and
Advertisements",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2019-08-16T04:00:00Z,2019,8,2019-08-16T04:00:00Z,2019-11-28T04:59:59Z,2019-11-29T02:00:38Z,2019-17481,0,0,0900006483e5f2f7
FDA-2019-F-3519-0001,FDA,FDA-2019-F-3519,Kellogg Company; Filing of Food Additive Petition,Proposed Rule,Petition,2019-08-12T04:00:00Z,2019,8,2019-08-12T04:00:00Z,,2019-08-12T15:16:10Z,2019-17056,0,0,0900006483e2d684
FDA-2019-D-0892-0023,FDA,FDA-2019-D-0892,The Use of an Alternate Name for Potassium Chloride in Food Labeling; Draft Guidance for Industry; Extension of Comment Period,Proposed Rule,Extension of Comment Period,2019-07-10T04:00:00Z,2019,7,2019-07-10T04:00:00Z,2019-09-18T03:59:59Z,2019-09-19T01:04:17Z,2019-14666,0,0,0900006483d74b33
FDA-2019-N-1363-0001,FDA,FDA-2019-N-1363,Biologics License Applications and Master Files,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2019-06-28T04:00:00Z,2019,6,2019-06-28T04:00:00Z,2019-08-28T03:59:59Z,2019-08-28T01:03:12Z,2019-13753,0,0,0900006483d4af9c
FDA-2019-N-2514-0001,FDA,FDA-2019-N-2514,Standards for Future Opioid Analgesic Approvals and Incentives for New Therapeutics to Treat Pain and Addiction,Proposed Rule,Public Hearing,2019-06-21T04:00:00Z,2019,6,2019-06-21T04:00:00Z,2019-11-19T04:59:59Z,2019-11-23T02:00:56Z,2019-13219,0,0,0900006483d2f7ad
FDA-2016-N-3818-0068,FDA,FDA-2016-N-3818,Content and Format of Substantial Equivalence Reports; Food and Drug Administration Actions on Substantial Equivalence Reports; Extension of Comment Period,Proposed Rule,Extension of Comment Period,2019-06-13T04:00:00Z,2019,6,2019-06-13T04:00:00Z,2019-07-18T03:59:59Z,2019-06-13T21:14:01Z,2019-12478,0,0,0900006483d0d911
FDA-2019-D-0892-0001,FDA,FDA-2019-D-0892,"The Use of an Alternate Name for Potassium Chloride in Food Labeling;
Draft Guidance for Industry; Availability",Proposed Rule,GDL Guidance,2019-05-20T04:00:00Z,2019,5,2019-05-20T04:00:00Z,2019-07-20T03:59:59Z,2019-07-11T01:05:50Z,2019-10401,0,0,0900006483ca0db2
FDA-2019-C-1782-0001,FDA,FDA-2019-C-1782,"CooperVision, Inc.; Filing of Color Additive Petition",Proposed Rule,Petition,2019-05-08T04:00:00Z,2019,5,2019-05-08T04:00:00Z,,2019-05-08T13:39:36Z,2019-09411,0,0,0900006483c43a7a
FDA-2019-N-1250-0001,FDA,FDA-2019-N-1250,General and Plastic Surgery Devices; Reclassification of Certain Surgical Staplers,Proposed Rule,Amendment,2019-04-24T04:00:00Z,2019,4,2019-04-24T04:00:00Z,2019-06-25T03:59:59Z,2019-06-25T01:01:16Z,2019-08260,0,0,0900006483be9aa2
FDA-2015-F-0537-0053,FDA,FDA-2015-F-0537,Natural Resources Defense Council et al.: Response to the Objections and Denial of the Requests for a Public Hearing,Proposed Rule,Denial,2019-04-24T04:00:00Z,2019,4,2019-04-24T04:00:00Z,,2019-04-24T15:54:26Z,2019-08262,0,0,0900006483be9aef
FDA-2018-D-2074-0001,FDA,FDA-2018-D-2074,Initiation of Voluntary Recalls Draft Guidance for Industry and Food and Drug Administration Staff; Availability,Proposed Rule,GDL Guidance,2019-04-24T04:00:00Z,2019,4,2019-04-24T04:00:00Z,2019-06-25T03:59:59Z,2019-06-25T01:01:12Z,2019-08198,0,0,0900006483be94d9
FDA-1978-N-0018-1649,FDA,FDA-1978-N-0018,Sunscreen Drug Products for Over-the-Counter Human Use; Correction,Proposed Rule,Correction,2019-04-18T04:00:00Z,2019,4,2019-04-18T04:00:00Z,2019-06-28T03:59:59Z,2024-04-16T20:27:21Z,2019-07712,0,0,0900006483bb94cb
FDA-1978-N-0018-1648,FDA,FDA-1978-N-0018,"Sunscreen Drug Products for Over-the-Counter Human Use; Extension of
Comment Period",Proposed Rule,Extension of Comment Period,2019-04-18T04:00:00Z,2019,4,2019-04-18T04:00:00Z,2019-06-28T03:59:59Z,2019-09-24T01:03:41Z,2019-07710,0,0,0900006483bb93d6
FDA-2019-N-1132-0001,FDA,FDA-2019-N-1132,"The Future of Insulin Biosimilars: Increasing Access and Facilitating the
Efficient Development of Biosimilar and Interchangeable Insulin Products; Public Hearing; Request for Comments",Proposed Rule,Request for Comment,2019-04-03T04:00:00Z,2019,4,2019-04-03T04:00:00Z,2019-06-01T03:59:59Z,2019-06-26T01:02:18Z,2019-06438,0,0,0900006483b5e6e5
FDA-2018-N-1815-0001,FDA,FDA-2018-N-1815,Beverages: Bottled Water,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2019-04-03T04:00:00Z,2019,4,2019-04-03T04:00:00Z,2019-06-04T03:59:59Z,2019-06-05T01:02:17Z,2019-06201,0,0,0900006483b5e4c0
FDA-2019-N-1482-0001,FDA,FDA-2019-N-1482,"Scientific Data and Information About Products Containing Cannabis or
Cannabis-Derived Compounds; Public Hearing; Request for Comments",Proposed Rule,Request for Comment,2019-04-03T00:00:00Z,2019,4,2019-04-03T00:00:00Z,,2025-05-14T18:16:19Z,2019-06436,0,0,0900006483b5e3f8
FDA-2016-N-3818-0001,FDA,FDA-2016-N-3818,"Content and Format of Substantial Equivalence Reports; Food and Drug
Administration Actions on Substantial Equivalence Reports",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2019-04-02T04:00:00Z,2019,4,2019-04-02T04:00:00Z,2019-07-18T03:59:59Z,2019-07-19T01:00:36Z,2019-05787,0,0,0900006483b571a6
FDA-2018-N-4757-0001,FDA,FDA-2018-N-4757,Revocation of the Test for Mycoplasma,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2019-04-02T04:00:00Z,2019,4,2019-04-02T04:00:00Z,2019-06-18T03:59:59Z,2019-06-14T01:01:26Z,2019-06188,0,0,0900006483b571a2
FDA-2018-N-3303-0001,FDA,FDA-2018-N-3303,"Radiological Health Regulations; Amendments to Records and Reports
for Radiation Emitting Electronic Products; Amendments to Performance Standards for Diagnostic X-Ray, Laser and Ultrasonic Products",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2019-04-01T04:00:00Z,2019,4,2019-04-01T04:00:00Z,2019-07-02T03:59:59Z,2019-07-02T01:01:57Z,2019-05822,0,0,0900006483b51258
FDA-2013-N-0134-0006,FDA,FDA-2013-N-0134,Mammography Quality Standards Act,Proposed Rule,Amendment,2019-03-28T04:00:00Z,2019,3,2019-03-28T04:00:00Z,2019-06-27T03:59:59Z,2019-07-03T01:05:03Z,2019-05803,0,0,0900006483b38569
FDA-2019-F-0670-0002,FDA,FDA-2019-F-0670,Uralkali PSJ; Filing of Food Additive Petition,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2019-03-28T04:00:00Z,2019,3,2019-03-28T04:00:00Z,2019-04-30T03:59:59Z,2019-04-05T01:01:30Z,2019-05954,0,0,0900006483b38522
FDA-2017-F-0969-0002,FDA,FDA-2017-F-0969,Food Additives Permitted in Feed and Drinking Water of Animals; Spent Bleaching Clay,Proposed Rule,Amendment,2019-03-19T04:00:00Z,2019,3,2019-03-19T04:00:00Z,2019-04-19T03:59:59Z,2019-04-19T01:00:27Z,2019-05103,0,0,0900006483aff21b
FDA-2018-D-1398-0025,FDA,FDA-2018-D-1398,Mitigation Strategies To Protect Food Against Intentional Adulteration: Draft Guidance for Industry; Public Meeting; Request for Comments,Proposed Rule,Public Meeting,2019-03-19T04:00:00Z,2019,3,2019-03-19T04:00:00Z,2019-07-06T03:59:59Z,2019-07-06T01:00:39Z,2019-05149,0,0,0900006483afebda
FDA-2018-N-4394-0001,FDA,FDA-2018-N-4394,Medical Devices; Exemption From Premarket Notification: Class II Devices; Flow Cytometer Instruments; Request for Comments,Proposed Rule,Request for Comment,2019-03-06T05:00:00Z,2019,3,2019-03-06T05:00:00Z,2019-05-07T03:59:59Z,2019-05-07T01:01:08Z,2019-03967,0,0,0900006483ac2460
FDA-1978-N-0018-0841,FDA,FDA-1978-N-0018,Sunscreen Drug Products for Over-the-Counter Human Use,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2019-02-26T05:00:00Z,2019,2,2019-02-26T05:00:00Z,2019-05-29T03:59:59Z,2019-05-30T01:07:25Z,2019-03019,0,0,0900006483aa7022
FDA-2018-N-2727-0042,FDA,FDA-2018-N-2727,Institutional Review Board Waiver or Alteration of Informed Consent for Minimal Risk Clinical Investigations; Reopening of Comment Period,Proposed Rule,Extension of Comment Period,2019-02-25T05:00:00Z,2019,2,2019-02-25T05:00:00Z,2019-03-08T04:59:59Z,2019-03-09T02:02:09Z,2019-03195,0,0,0900006483aa313c
FDA-1976-N-0476-0426,FDA,FDA-1976-N-0476,Nonclinical Laboratory Studies; Amendment of Good Laboratory Practice Regulations,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2019-01-30T05:00:00Z,2019,1,2019-01-30T05:00:00Z,1980-02-05T04:59:59Z,2019-01-30T19:00:27Z,79-36991,0,0,0900006480521aa5
FDA-1976-N-0476-0001,FDA,FDA-1976-N-0476,"Nonclinical Laboratory Studies Proposed Regulations for Good Laboratory
Practice Regulations",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2019-01-29T05:00:00Z,2019,1,2019-01-29T05:00:00Z,1977-03-22T04:59:59Z,2019-01-29T15:28:47Z,76-34014,0,0,0900006480521944
FDA-1976-N-0476-0081,FDA,FDA-1976-N-0476,"Nonclinical Laboratory Studies, Proposed Regulations for Good Laboratory Practice; Correction",Proposed Rule,Correction,2019-01-29T05:00:00Z,2019,1,2019-01-29T05:00:00Z,,2019-01-29T16:41:17Z,77-2405,0,0,090000648052195a